Summary The roles of exogenous sex hormones and reproductive factors in the causation of malignant melanoma of the skin in women were examined in a case-control study of 276 patients and 276 matched controls in Western Australia. There was no consistent evidence of a relationship between the incidence rates of different histogenetic types of melanoma and age at menarche, duration of menstrual life, degree of obesity, number of pregnancies more than 20 weeks in duration or use of oral contraceptive preparations (OCP). Exposure to OCP was examined separately for different age periods and in different intervals of time before diagnosis; no consistent trend emerged. There was borderline evidence of an association of superficial spreading melanoma with duration of use of unopposed oestrogens. On the basis of seven studies of the relationship of melanoma to OCP published to date, we estimate that the total incidence rate of melanoma in OCP ever-users is unlikely to be increased by more than one third the rate in never-users.
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There is a physiological basis for the hypothesis that the frequency of malignant melanoma in women is influenced by hormonal or reproductive factors. Oestrogens alone, and combinations of oestrogens and progesterone, stimulate melanocyte division and melanogenic activity. These effects have been observed in animal experiments (Snell & Bischitz, 1960) and are presumably the underlying cause of hyperpigmentation in women taking oral contraceptives (Jelinek, 1970) . Increased cell division and cellular activity are recognised as general properties of cancer promoters (Greenbaum & Weinstein, 1975) . Oestrogen receptors have been found in cells from 12% to 46% of human melanomas (Fisher et al., 1976; Creagan et al., 1980) . Sadoff et al. (1973) and Lee & Storer (1980) have proposed that a hormonal factor, possibly related to childbearing, may increase the risk of melanoma in premenopausal women. Their view is supported by peaks in the ratios of female to male rates of melanomas of the skin and eye in the later years of reproductive life (Lee & Storer, 1981; 1982) , and by anecdotal evidence that pregnancy may promote melanoma growth (Allen, 1955; Stewart, 1955) . Despite these descriptive observations, in which some discrepancies have been noted (Holman & Armstrong, 1981) , the relationship of melanoma to reproductive factors such as number of pregnancies has been quantified only recently (Holly et al., 1983) .
At least six studies have examined the relationship of melanoma to oral contraceptives (OCP) and other oestrogenic preparations (Beral et al., 1977; Ramcharan et al., 1981 Kay, 1981; Bain et al., 1982; Helmrich et al., 1983 unpublished; Holly et al., 1983) . In one of the two positive studies a specific association was observed between OCP use and superficial spreading melanoma, but apparently not with other histogenetic subtypes (Holly et al., 1983) .
In this report we present results from a casecontrol study of cutaneous malignant melanoma in Western Australia. Our aim is to evaluate further the putative role of female sex hormones, both endogenous and exogenous, in the aetiology of different melanoma subtypes.
Materials and methods
The sources of study subjects and methods of data collection and analysis have been described in detail in previous reports from the West Australian Lions Melanoma Research Project (Holman 1983; Holman & Armstrong, 1983 , 1984 . In this report, the analysis has been confined to women.
In brief, the cases were 278 female patients with histologically proven preinvasive or invasive melanoma. For each case, a female control subject matched on 5-year birth period and electoral subdivision was randomly selected from the Australian Commonwealth Electoral Roll. For 7 cases aged <18 years, female controls of the same age were randomly selected from the student roll of a public school. In all 458 potential controls were selected, of whom 12% were untraceable and 27% refused to participate.
The methods used to contact potential participants and to solicit their cooperation were identical for cases and controls. Subjects were initially contacted by mail and were visited either at home (97%) or in the workplace by a trained nurse interviewer who administered a highly structured questionnaire entitled "Environment, Lifestyle and Health". The purpose of the interview was not otherwise stated, and as far as possible the interviewers were not informed of which subjects were cases and which were controls.
A wide range of possible causal factors, including constitutional and hereditary factors, sun exposure, diet and exposures to known or suspected carcinogens were explored during the interview. Of relevance to this report were menstrual and obstetric histories, weight and height measured by the interviewer, and history of use of OCP or other oestrogenic preparations.
All except one case and her matching control were postpubertal, and were asked the age at which their first menstrual period had occurred and if they still had periods. Women whose periods had ceased for at least one year, and who were not pregnant or breast feeding, were asked their age at their last menstrual period, and whether menopause had occurred naturally or as the result of a surgical procedure. Subjects were asked if they had ever been pregnant, and if so, their number of pregnancies of 20 or more weeks in duration, their age at first pregnancy and the interval since their last pregnancy. Using the measurements obtained by interviewers, Quetelet's index was calculated as weight/height2.
For women who had ever used OCPs or other oestrogenic preparations, a separate record of each interval of use was made, including the first and last years and duration of use to the nearest month. To assist recall, subjects were shown a list of trade names of OCP available in Western Australia, and a list of trade names of other preparations containing oestrogens.
The methods of analysis followed those described by Breslow & Day (1981) 
Results

Menstrual history
The estimated effects of age at menarche on the incidence rates of all melanomas combined and of each histogenetic type are shown in Table I Obesity Degree of obesity assessed by Quetelet's index was studied because of the known association of plasma oestrogen levels with obesity, especially in postmenopausal women (de Waard, 1982) . The relationships of melanoma subtypes to Quetelet's index measured at the time of interview are shown in Table III . There was no evidence of any relationship in these results, nor in results obtained when the analyses of all melanomas and SSM were restricted to postmenopausal women. C34 and 5 + pregnancies combined. Because of the possibility of confounding, the relationship of SSM to duration of OCP use was re-examined controlling for SSM risk factors identified elsewhere in the study. These were skin reaction to sunlight, hair colour, number of raised naevi on the arms, age at arrival of migrants to Australia, level of residential sun exposure and degree of weekend recreational sun exposure at ages 10-24 and frequencies of outdoor activities in summer (Holman, 1983; Holman & Armstrong, 1984) . The odds ratios observed following inclusion of these factors in the conditional logistic regression model were 0.78 (0.32-1.94) in women using OCP for less than 2 years, 2.24 (0.73-6.81) for 2-4 years of use, and 1.62 (0.53-4.93) in women with a history of 5 or more years of OCP use.
The associations of all melanomas and melanoma subtypes with OCP use were also examined within intervals of 10 or more years, 5-9 years and less than 5 years before diagnosis of the case (Table V) . The odds ratios in Table V compare OCP everusers with never-users ascertained solely on the basis of exposure information derived from each time period. Except for HMF, which had odds ratios associated with very wide confidence intervals, there was little empirical evidence of an effect of OCP use in any of the time periods under study. A similar analysis was performed on exposure to OCP within each of the age intervals 10-19 years, 20-29 years and 30 or more years, again without consistent evidence of any effect.
Other oestrogenic preparations Fourteen per cent of subjects had ever taken hormone tablets or injections containing an oestrogen but no progestagen. Reasons for prescription of the preparations included alleviation of symptoms of menopause (59%), regulation of menstrual bleeding (19%) and indications related to pregnancy and lactation (19%) . In ever-users of unopposed oestrogens the odds ratios were 1.52 (0.87-2.66, P=0.149) for all melanomas and 1.91 (0.88-4.22, P=0.112) for SSM. bNumber of case-control pairs.
C2-4 y and 5 + y combined.
dEver-use of OCP. bNumber of case-control pairs.
cNo exposed subjects. The analysis of SSM with duration of oestrogen use was also repeated controlling for SSM risk factors previously identified. This analysis produced no overall loss in the strength of association of SSM with oestrogen use, but did produce inconsistency in the trend in odds ratios. The adjusted odds ratios were 2.51 (0.71-8.87) in women who used oestrogens for 12 months or less, and 2.15 (0.52-8.55) for use of greater than 12 months.
Discussion
It is widely known that Australia has a high incidence rate of malignant melanoma, generally thought to result from high levels of sunlight exposure. In the presence of other exposures such as sunlight, incidence rate ratios for hormonal factors could be altered substantially, depending on the nature of any effect modification that might occur. It may be unwise, therefore, to assume that our results may be generalised to low incidence populations as readily as they might be to other high incidence populations.
With this proviso, the results of this study give no support for a role of endogenous sex hormones or related phenomena in the aetiology of melanoma in women. None of the histogenetic subtypes appeared to occur at an increased rate in association with early age at menarche, long duration of menstrual life or obesity. similarly, Holly et al. (1983) found no relationship of either SSM or all melanomas as a group with age at menopause or body weight of women at age 30 years. In contrast cancers of the breast and endometrium, both thought to be promoted by oestrogens, show associations with early menarche, late menopause and obesity (Petrakis et al., 1982; de Waard, 1982) .
Contrary to past suspicions that oestrogens, and perhaps pregnancy as a consequence, may be a promotional factor, we, like Holly et al. (1983) , observed no association of melanoma with number of pregnancies. Holly et al. (1983) did report a 3-fold increase in the rate of SSM in women who delayed childbearing until age 31 years or older compared with those aged 20 years or less at the birth of their first child. In this study only 4% of subjects first bore a child at over 30 years of age. Thus, our results cannot necessarily argue against an effect of very late childbearing, although we find this hypothesis difficult to reconcile with the apparent lack of an increased risk in nulliparous women. Nevertheless, our results should not be interpreted as completely inconsistent with those of Holly et al. (1983) , since the upper bounds of our confidence intervals for the crude odds ratios in long term OCP users were around 3-4 and the upper bounds for odds ratios with possible confounding variables controlled were near 5-7.
The borderline finding of association of SSM with unopposed oestrogen use in this study appeared to be largely unexplained by any confounding effect. This result warrants further investigation. However, in view of the lack of association of SSM with indicators of endogenous oestrogen exposure, and the negative results of Holly et al. (1983) , chance is perhaps the most likely explanation.
In any future study of the role of OCPs or other oestrogens in melanoma causation it will be important to perform separate analyses on the histogenetic subtypes of melanoma. An investigator reporting a positive result should also be able to demonstrate that the association is not due to confounding by factors related to sunlight exposure habits which, at least in an extension of the Walnut Creek Contraceptive Drug Study (Ramcharan et al., 1981) , appeared to differ between OCP users and non-users.
